Patent ID: 11885817
Assignee: COGNIZANCE BIOMARKERS, LLC
Field: Measurement (Instruments)
Classification: CPC G  A  C | IPC C  G

Claim 3:
4. A method of treating epilepsy in a patient having an elevated blood level of one or more biomarkers selected from the group consisting of thymus and activation-regulated chemokine (TARC), interleukin (IL)-7, monocyte chemotactic protein (MCP)-4, macrophage colony-stimulating factor (M-CSF), MCP-2, IL-8, macrophage inflammatory protein (MIP)-1B, macrophage migration inhibitory factor (MIF), Eotaxin, MIP-5, IL-15, Eotaxin-2, TNF-RI, interferon gamma-induced protein 10 (IP-10), granulocyte macrophage colony stimulating factor (GM-CSF), IL-12p70, and IL-1B; the method comprising administering to the patient one or more therapeutic agents selected from the group consisting of phenytoin, carbamazepine, lamotrigine, oxcarbazepine, zonisamide, and pharmaceutically acceptable salts and prodrugs thereof.